0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessMonotherapy with once daily doses of lurasidone 20-60 mg, but not 80-120 mg, significantly reduced depressive symptoms and improved functioning in patients with bipolar I depression. Results overall were consistent with previous studies, suggesting that lurasidone 20-60 mg/day is effective and safe in diverse ethnic populations, including Japanese.
Tadafumi Kato, Jun Ishigooka, Mari Miyajima, Kei Watabe, Tomohiro Fujimori, Takahiro Masuda, Teruhiko Higuchi, Eduard Vieta (2020). <scp>Double‐blind</scp>, <scp>placebo‐controlled</scp> study of lurasidone monotherapy for the treatment of bipolar I depression. , 74(12), DOI: https://doi.org/10.1111/pcn.13137.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2020
Authors
8
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1111/pcn.13137
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
